, Lancet, vol.391, pp.1301-1315, 2018.
Evolution of the cancer stem cell model, Cell Stem Cell, vol.14, pp.275-91, 2014. ,
Oncofetal signaling as a target for cancer therapy, Semin Cancer Biol, vol.29, pp.1-2, 2014. ,
Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance, Gut, vol.68, pp.1858-71, 2019. ,
Hepatic leukemia factor maintains quiescence of hematopoietic stem cells and protects the stem cell pool during regeneration, Cell Rep, vol.21, pp.3514-3537, 2017. ,
Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options, Nat Genet, vol.47, pp.1020-1029, 2015. ,
The HLF/IL-6/ STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis, Gut, vol.67, pp.1704-1719, 2018. ,
Retrodifferentiation of human tumor hepatocytes to stem cells leads to metabolic reprogramming and chemoresistance, Cancer Res, vol.79, pp.1869-83, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02087900
Oncogene at last--c-Jun promotes liver cancer in mice, Cancer Cell, vol.3, pp.102-106, 2003. ,
Activation of c-Jun predicts a poor response to sorafenib in hepatocellular carcinoma, Preliminary Clinical Evidence. Sci Rep, vol.6, p.22976, 2016. ,
Is adaptive therapy natural?, PLoS Biol, vol.16, p.2007066, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01887358